Dr. Nataliya Uboha is a faculty member in the Division of Hematology, Medical Oncology, and Palliative Care within the Department of Medicine. On a state level, she is a co-director of Wisconsin Oncology Network, which is a regional network of cancer clinics that aligns community and academic health centers to bring novel cancer treatments to patients in the community. Dr. Uboha is a nationally recognized expert in gastroesophageal malignancies and neuroendocrine tumors. She co-Chairs the Big 10 Cancer Research Consortium GI Section and is a member of the National Cancer Institute upper GI task force. Dr. Uboha is also a member of NCCN committee for neuroendocrine malignancies.
Dr. Uboha’s clinical interests include gastrointestinal cancers, with a particular emphasis on hepatobiliary and gastroesophageal cancers.
Her research focuses on the development of early phase and biomarker based clinical trials for patients with gastrointestinal malignancies. She has significant clinical trial experience, serving as a principal investigator on multiple investigator-initiated and industry sponsored studies. She is an active member of the UW Carbone Cancer Center Phase 1 group. Dr. Uboha also co-leads the Basket Disease Oriented Team (DOT), which has a specific focus on biomarker based trials across disease types.